Study
Commercial ProductionRecentStrong effect

Tailoring Eudragit® Copolymer Ratios Optimizes Drug Delivery Performance

The precise ratio of methacrylic acid to methacrylate monomers during Eudragit® copolymer synthesis directly dictates its performance characteristics, enabling targeted applications in drug delivery.

Pharmaceutics · 2023

01

Key Findings

  • 01The ratio of methacrylic acid to methacrylate monomers is the primary determinant of Eudragit® copolymer properties.
  • 02These tunable properties enable applications such as enteric coating, controlled temporal release, and targeted gastrointestinal delivery.
  • 03Eudragit® polymers have a long history of use in healthcare, dating back to 1953.
02

Application

Design takeaway

When developing pharmaceutical products requiring precise drug release or targeting, carefully select or engineer Eudragit® copolymers by controlling their monomer ratios to match the desired performance specifications.

How to apply

When designing a new drug delivery system, consult Eudragit® product datasheets and literature to identify or specify the copolymer grade with monomer ratios best suited for the target release profile and administration route.

Project actions

  • 01When researching materials for a design project, look for polymers where the ratio of different chemical building blocks can be adjusted to change their properties.
  • 02Consider how changing the composition of a material can lead to different functional outcomes for your product.
03

Method & Evidence

AimHow does the ratio of methacrylic acid to methacrylate monomers in Eudragit® copolymers influence their performance in smart healthcare applications?
MethodSystematic Review
ProcedureThe review systematically analyzed existing literature on Eudragit® polymers, from their molecular structure and synthesis to their characterization and diverse applications in healthcare, focusing on how monomer ratios impact material properties and functionality.
ContextPharmaceuticals and Healthcare

Variables

IVRatio of methacrylic acid to methacrylate monomers in Eudragit® copolymer.
DVPerformance characteristics (e.g., enteric coating efficacy, drug release rate, targeting ability).
CVPolymerization method, specific monomers used, molecular weight, processing conditions.
04

Strengths & Limitations

Strengths

  • +Provides a comprehensive overview of Eudragit® polymers.
  • +Highlights the critical role of monomer ratios in determining material properties and applications.

Limitations

Access to specific Eudragit® grades with precisely known monomer ratios for experimental testing might be limited. The review relies on published data, which may have its own inherent limitations.

Reliability & validity

The reliability of the findings is based on a systematic review of peer-reviewed literature. Validity is supported by the consistent reporting of monomer ratio-property relationships across multiple studies.

Think critically

Beyond monomer ratios, what other factors (e.g., molecular weight, processing conditions) significantly influence the performance of Eudragit® polymers in healthcare applications?

05

Design Principles

"Material properties are a direct function of their constituent ratios and synthesis conditions, enabling tailored performance for specific applications."

Understanding and controlling the monomer composition of Eudragit® polymers is crucial for designing advanced drug delivery systems. This allows for the precise tuning of properties like solubility, release rate, and targeting, which are critical for product efficacy and patient compliance in pharmaceutical applications.

06

What This Means for Your Design

The recipe for making Eudragit® plastic determines what it can do, like making pills dissolve at the right time or in the right place in your body.

How to use in your project

  • 1.Reference this study when discussing the selection and justification of materials for a design project, particularly if using polymers with tunable properties.
07

Add to My Project

08

Quick Cite

(2023). A Systematic Overview of Eudragit® Based Copolymer for Smart Healthcare. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15020587 Retrieved from https://designdex.org/study/ba7f6148-3251-4cd3-b044-80bb138d6059/tailoring-eudragit-copolymer-ratios-optimizes-drug-delivery-performance

Paragraph starter

The synthesis of Eudragit® copolymers, a key material in advanced healthcare applications, is directly controlled by the ratio of methacrylic acid to its methacrylate-based monomers. This ratio is critical as it dictates the polymer's physicochemical properties, such as solubility and permeability, thereby enabling tailored functionalities like enteric coating and controlled drug release. Understanding this relationship allows for informed material selection and design in pharmaceutical development.

09

Source

Pharmaceutics

A Systematic Overview of Eudragit® Based Copolymer for Smart Healthcare

journal · 2023

View source

Questions about this research

What does the research say about tailoring eudragit® copolymer ratios optimizes drug delivery performance?
When developing pharmaceutical products requiring precise drug release or targeting, carefully select or engineer Eudragit® copolymers by controlling their monomer ratios to match the desired performance specifications. Evidence: Pharmaceutics (2023).
Why does "Tailoring Eudragit® Copolymer Ratios Optimizes Drug Delivery Performance" matter for design?
Understanding and controlling the monomer composition of Eudragit® polymers is crucial for designing advanced drug delivery systems. This allows for the precise tuning of properties like solubility, release rate, and targeting, which are critical for product efficacy and patient compliance in pharmaceutical applications.
How can designers apply this research?
When developing pharmaceutical products requiring precise drug release or targeting, carefully select or engineer Eudragit® copolymers by controlling their monomer ratios to match the desired performance specifications.
What were the main findings?
The ratio of methacrylic acid to methacrylate monomers is the primary determinant of Eudragit® copolymer properties.. These tunable properties enable applications such as enteric coating, controlled temporal release, and targeted gastrointestinal delivery.. Eudragit® polymers have a long history of use in healthcare, dating back to 1953.
What research method was used?
Systematic Review.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2023 journal from Pharmaceutics.
What should I do differently in my next project?
When designing a new drug delivery system, consult Eudragit® product datasheets and literature to identify or specify the copolymer grade with monomer ratios best suited for the target release profile and administration route.
What are the limitations?
The review focuses on existing knowledge and may not cover novel or proprietary Eudragit® formulations. Specific performance data for every possible monomer ratio may not be available.
Is there evidence that eudragit affects design outcomes?
The specific blend of methacrylic acid and methacrylate monomers used to create Eudragit® polymers is the key factor that determines how they will perform, allowing them to be used for specialized medical purposes like protecting medications in the stomach or releasing them slowly over time. Understanding and controlli Source: Pharmaceutics (2023).
Where does this eudragit copolymer research apply?
Pharmaceuticals and Healthcare It sits within commercial production research on designdex.org.

Related research topics

eudragit design research · evidence on eudragit · does eudragit improve design outcomes · eudragit copolymer studies for designers · eudragit and eudragit copolymer findings · commercial production research evidence